Vol 8, No 1 (2022)
Review paper
Published online: 2022-04-01
Page views 4029
Article views/downloads 27
Get Citation

Connect on Social Media

Connect on Social Media

Czerniak akralny — praktyczne wskazówki diagnostyczne

Michał Sobjanek1, Aleksandra Rosiak-Buller2, Martyna Sławińska1
Forum Dermatologicum 2022;8(1):17-29.

Abstract

Czerniak akralny to pojęcie, które odnosi się do czerniaków występujących na dłoniowej powierzchni rąk, podeszwowej powierzchni stóp oraz w obrębie aparatu paznokciowego. Nowotwór ten w populacji kaukaskiej występuje stosunkowo rzadko, przez co może sprawiać trudności diagnostyczne. W pracy omówiono obraz kliniczny, znaczenie dermoskopii w diagnostyce nowotworu, spektrum rozpoznań różnicowych oraz zarys postępowania diagnostyczno-terapeutycznego, ze szczególnym uwzględnieniem aspektów przydatnych w codziennej praktyce klinicznej.

Article available in PDF format

Add to basket: 49.00 PLN

Aready have access?

References

  1. Reed R. Acral lentiginous melanoma. In: Hartmann W, Reed R. ed. New Concepts in Surgical Pathology of the Skin. John Wiley & Sons, New York 1976: 89–90.
  2. Kuchelmeister C, Schaumburg-Lever G, Garbe C. Acral cutaneous melanoma in caucasians: clinical features, histopathology and prognosis in 112 patients. Br J Dermatol. 2000; 143(2): 275–280.
  3. Czerwińska M, Alekseenko A, Rup E, et al. Retrospective data analysis of the history of patients treated for malignant melanoma at the Department of Dermatology, Jagiellonian University between 1991 and 2008. Post Dermatol Alergol. 2011; 28: 92–96.
  4. Csányi I, Houshmand N, Szűcs M, et al. Acral lentiginous melanoma: a single-centre retrospective review of four decades in East-Central Europe. J Eur Acad Dermatol Venereol. 2020; 34(9): 2004–2010.
  5. Feinsilber D, Díaz F, Schroh R. Melanoma acral lentiginoso: variante subungueal en un niño. Med Cutan Iber Lat Am. 2016; 44(1): 52–56.
  6. Bradford PT, Goldstein AM, McMaster ML, et al. Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986-2005. Arch Dermatol. 2009; 145(4): 427–434.
  7. Brazen BC, Gray T, Farsi M, et al. Acral lentiginous melanoma: a rare variant with unique diagnostic challenges. Cureus. 2020; 12(6): e8424.
  8. Jackson CR, Fernelius C, Arora N. Ramifications of poor medical education and screening in minority populations: an extensive acral melanoma. BMJ Case Rep. 2015; 2015.
  9. Lino-Silva LS, Zepeda-Najar C, Salcedo-Hernández RA, et al. Acral lentiginous melanoma: survival analysis of 715 cases. J Cutan Med Surg. 2019; 23(1): 38–43.
  10. Durbec F, Martin L, Derancourt C, et al. Melanoma of the hand and foot: epidemiological, prognostic and genetic features. A systematic review. Br J Dermatol. 2012; 166(4): 727–739.
  11. Bristow IR, de Berker DAr, Acland KM, et al. Clinical guidelines for the recognition of melanoma of the foot and nail unit. J Foot Ankle Res. 2010; 3: 25.
  12. Elefanti L, Zamuner C, Del Fiore P, et al. The molecular landscape of primary acral melanoma: a multicenter study of the Italian melanoma intergroup (IMI). Int J Mol Sci. 2021; 22(8).
  13. Juzeniene A, Baturaite Z, Moan J. Sun exposure and melanomas on sun-shielded and sun-exposed body areas. Adv Exp Med Biol. 2014; 810: 375–389.
  14. Al-Hassani F, Chang C, Peach H. Acral lentiginous melanoma – Is inflammation the missing link? JPRAS Open. 2017; 14: 49–54.
  15. Briggs JC. The role of trauma in the aetiology of malignant melanoma: a review article. Br J Plast Surg. 1984; 37(4): 514–516.
  16. Levit EK, Kagen MH, Scher RK, et al. The ABC rule for clinical detection of subungual melanoma. J Am Acad Dermatol. 2000; 42(2 Pt 1): 269–274.
  17. Di Chiacchio N, Hirata SH, Enokihara MY, et al. Dermatologists' accuracy in early diagnosis of melanoma of the nail matrix. Arch Dermatol. 2010; 146(4): 382–387.
  18. Ko D, Oromendia C, Scher R, et al. Retrospective single-center study evaluating clinical and dermoscopic features of longitudinal melanonychia, ABCDEF criteria, and risk of malignancy. J Am Acad Dermatol. 2019; 80(5): 1272–1283.
  19. Hoorens I, Vossaert K, Lanssens S, et al. Value of dermoscopy in a population-based screening sample by dermatologists. Dermatol Pract Concept. 2019; 9(3): 200–206.
  20. Desai A, Ugorji R, Khachemoune A. Acral melanoma foot lesions. Part 2: clinical presentation, diagnosis, and management. Clin Exp Dermatol. 2018; 43(2): 117–123.
  21. Han D, Zager JS, Shyr Yu, et al. Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma. J Clin Oncol. 2013; 31(35): 4387–4393.
  22. Bradford PT, Goldstein AM, McMaster ML, et al. Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986-2005. Arch Dermatol. 2009; 145(4): 427–434.
  23. Ogata D, Uhara H, Tsutsumida A, et al. Nail apparatus melanoma in a Japanese population: a comparative study of surgical procedures and prognoses in a large series of 151 cases. Eur J Dermatol. 2017; 27(6): 620–626.
  24. Jung JM, Jung CJ, Won CH, et al. Different progression pattern between acral and nonacral melanoma: A retrospective, comparative, clinicoprognostic study of 492 cases of primary cutaneous melanoma according to tumor site. Indian J Dermatol Venereol Leprol. 2021; 87(4): 498–508.
  25. Shin HT, Jang KT, Mun GH, et al. Histopathological analysis of the progression pattern of subungual melanoma: late tendency of dermal invasion in the nail matrix area. Mod Pathol. 2014; 27(11): 1461–1467.
  26. Csányi I, Houshmand N, Szűcs M, et al. Acral lentiginous melanoma: a single-centre retrospective review of four decades in East-Central Europe. J Eur Acad Dermatol Venereol. 2020; 34(9): 2004–2010.
  27. Metzger S, Ellwanger U, Stroebel W, et al. Extent and consequences of physician delay in the diagnosis of acral melanoma. Melanoma Res. 1998; 8(2): 181–186.
  28. Rheingantz da Cunha Filho R, Matte L, Hohmann Camina R. Delay in diagnosis of acral melanoma. Dermatol Online J. 2016; 22(10).
  29. Suarez Gonzalez LA, Del Canto Peruyera P, Cerviño Alvarez J, et al. Misdiagnosed malignant tumor on an ischemic limb. Wounds. 2019; 31(2): E12–E13.
  30. Zhang J, Yang H, Lin J, et al. Primary acral amelanotic melanoma: A rare case report. Mol Clin Oncol. 2020; 13(5): 59.
  31. Sobjanek M, Włodarkiewicz A, Urban M, et al. Czerniak aparatu paznokciowego. Dermatol Estet. 2007; 9: 18–24.
  32. Sobjanek M, Włodarkiewicz A, Toboła J. Melanonychia longitudinalis. Post Dermatol Alergol. 2006; 23: 130–137.
  33. Sobjanek M, Michajłowski I, Biernat W, et al. Nail apparatus melanoma: epidemiological, clinical and histopathological analysis. Dermatol Rev. 2011; 98: 384–389.
  34. Tanaka M. Dermoscopy. J Dermatol. 2006; 33(8): 513–517.
  35. Lallas A, Kyrgidis A, Koga H, et al. The BRAAFF checklist: a new dermoscopic algorithm for diagnosing acral melanoma. Br J Dermatol. 2015; 173(4): 1041–1049.
  36. Saida T, Oguchi S, Miyazaki A. Dermoscopy for acral pigmented skin lesions. Clin Dermatol. 2002; 20(3): 279–285.
  37. Lallas A, Sgouros D, Zalaudek I, et al. Palmar and plantar melanomas differ for sex prevalence and tumor thickness but not for dermoscopic patterns. Melanoma Res. 2014; 24(1): 83–87.
  38. Saida T, Miyazaki A, Oguchi S, et al. Significance of dermoscopic patterns in detecting malignant melanoma on acral volar skin: results of a multicenter study in Japan. Arch Dermatol. 2004; 140(10): 1233–1238.
  39. Minagawa A, Koga H, Saida T. Dermoscopic characteristics of congenital melanocytic nevi affecting acral volar skin. Arch Dermatol. 2011; 147(7): 809–813.
  40. Chuah SY, Tsilika K, Chiaverini C, et al. Dermoscopic features of congenital acral melanocytic naevi in children: a prospective comparative and follow-up study. Br J Dermatol. 2015; 172(1): 88–93.
  41. Wawrzynkiewicz M, Wozniak W, Wojas-Pelc A, et al. Analiza wzorców dermoskopowych zmian melanocytowych zlokalizowanych w okolicach akralnych. Przegl Lek. 2013; 11: 911.
  42. Singal A, Bisherwal K. Melanonychia: etiology, diagnosis, and treatment. Indian Dermatol Online J. 2020; 11(1): 1–11.
  43. Tosti A, Baran R, Piraccini BM, et al. Nail matrix nevi: a clinical and histopathologic study of twenty-two patients. J Am Acad Dermatol. 1996; 34(5 Pt 1): 765–771.
  44. Kopf AW, Waldo E. Melanonychia striata. Australas J Dermatol. 1980; 21(2): 59–70.
  45. Baran R, Perrin C. Linear melanonychia due to subungual keratosis of the nail bed: a report of two cases. Br J Dermatol. 1999; 140(4): 730–733.
  46. André J, Lateur N. Pigmented nail disorders. Dermatol Clin. 2006; 24(3): 329–339.
  47. Bae SH, Lee MY, Lee JB. Distinct patterns and aetiology of chromonychia. Acta Derm Venereol. 2018; 98(1): 108–113.
  48. Kungvalpivat P, Rojhirunsakool S, Chayavichitsilp P, et al. Clinical and onychoscopic features of benign and malignant conditions in longitudinal melanonychia in the Thai population: a comparative analysis. Clin Cosmet Investig Dermatol. 2020; 13: 857–865.
  49. Di Chiacchio N, Ruben BS, Loureiro WR. Longitudinal melanonychias. Clin Dermatol. 2013; 31(5): 594–601.
  50. Perrin C, Michiels JF, Boyer J, et al. Melanocytes pattern in the normal nail, with special reference to nail bed melanocytes. Am J Dermatopathol. 2018; 40(3): 180–184.
  51. Rosiak-Buller A, Płaszczyńska A, Sławińska M, et al. Primary amelanotic melanoma of the nail bed. Dermatology Review. 2021; 108(4): 290–298.
  52. Elloumi-Jellouli A, Triki S, Driss M, et al. A misdiagnosed nail bed melanoma. Dermatol Online J. 2010; 16(7): 13.
  53. Riahi RR, Cohen PR, Goldberg LH. Subungual amelanotic melanoma masquerading as onychomycosis. Cureus. 2018; 10(3): e2307.
  54. Gradinaru TC, Mihai M, Beiu C, et al. Melanonychia - clues for a correct diagnosis. Cureus. 2020; 12(1): e6621.
  55. Wernick BD, Goel N, Zih FSw, et al. A surgical perspective report on melanoma management. Melanoma Manag. 2017; 4(2): 105–112.
  56. Doolan BJ, Robinson AJ, Wolfe R, et al. Accuracy of partial biopsies in the management of cutaneous melanoma. Australas J Dermatol. 2019; 60(3): 209–213.
  57. Duarte AF, Correia O, Barros AM, et al. Nail melanoma in situ: clinical, dermoscopic, pathologic clues, and steps for minimally invasive treatment. Dermatol Surg. 2015; 41(1): 59–68.
  58. Grover C, Bansal S. Nail Biopsy: A User's Manual. Indian Dermatol Online J. 2018; 9(1): 3–15.
  59. Goettmann S, Moulonguet I, Zaraa I. In situ nail unit melanoma: epidemiological and clinic-pathologic features with conservative treatment and long-term follow-up. J Eur Acad Dermatol Venereol. 2018; 32(12): 2300–2306.
  60. Nagore E, Moro R. Surgical procedures in melanoma: recommended deep and lateral margins, indications for sentinel lymph node biopsy, and complete lymph node dissection. Ital J Dermatol Venerol. 2021; 156(3): 331–343.
  61. Rutkowski P, Wysocko PJ, Kozak K, et al. Postępowanie diagnostyczno-terapeutyczne u chorych na czerniaki — zalecenia ekspertów [Ahead of Print]. Onkologia w Praktyce Klinicznej. 2021.
  62. Asgari MM, Shen L, Sokil MM, et al. Prognostic factors and survival in acral lentiginous melanoma. Br J Dermatol. 2017; 177(2): 428–435.
  63. Whiteman DC, Pavan WJ, Bastian BC. The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of origin. Pigment Cell Melanoma Res. 2011; 24(5): 879–897.
  64. Cust AE. Prognostic features for acral lentiginous melanoma. Br J Dermatol. 2018; 178(2): 311–312.
  65. Liu XK, Li J. Acral lentiginous melanoma. Lancet. 2018; 391(10137): e21.
  66. Ferrante di Ruffano L, Dinnes J, Deeks JJ, et al. Cochrane Skin Cancer Diagnostic Test Accuracy Group. Reflectance confocal microscopy for diagnosing cutaneous melanoma in adults. Cochrane Database Syst Rev. 2018; 12: CD013190.